title: Brucella and peritoneal dialysis related peritonitis: case report and review of literature.
abstract: Isolated case reports of peritonitis due to Brucella spp. during peritoneal dialysis (PD) continue to surface in the medical literature. However, the optimal treatment regimen for these patients, in particular with regards to the fate of PD catheter, is still largely unknown. We report a case of brucella peritonitis successfully treated with intraperitoneal administration of amikacin, along with oral rifampicin and doxycycline but without catheter removal. Furthermore, we have reviewed the literature up until present day.
authors.forename: Suleyman
authors.initials: S
authors.lastname: Koz
authors.forename: Idris
authors.initials: I
authors.lastname: Sahin
authors.forename: Uner
authors.initials: U
authors.lastname: Kayabas
authors.forename: Cigdem
authors.initials: C
authors.lastname: Kuzucu
mesh_terms: D000284:Administration, Oral; D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002006:Brucellosis / Q000188:drug therapy*; D055499:Catheter-Related Infections / Q000188:drug therapy*; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007274:Injections, Intraperitoneal; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000295:instrumentation*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000583:Amikacin; D004318:Doxycycline; D012293:Rifampin